Beth Israel Cancer Center — New York, New York

Beth Israel Cancer Center is a clinical research site located in New York, New York, United States 10003.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Beth Israel Cancer Center has participated in 5 clinical trials.

Therapeutic areas: Pancreatic Cancer, Ductal Adrenocarcinoma, Exocrine Pancreatic Cancer.

Sponsors: Pharmacyclics LLC., Dendreon, Helsinn Therapeutics (U.S.), Inc.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Beth Israel Cancer Center?

Beth Israel Cancer Center has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Beth Israel Cancer Center conducted?

Beth Israel Cancer Center has 5 clinical trials on record. Their work covers Pancreatic Cancer, Ductal Adrenocarcinoma, Exocrine Pancreatic Cancer.

Is Beth Israel Cancer Center accredited by Crixeo Health?

Yes — Beth Israel Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Beth Israel Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.